Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer
出版年份 2022 全文链接
标题
Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-8
出版商
Informa UK Limited
发表日期
2022-02-12
DOI
10.1080/21645515.2022.2035552
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
- (2021) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
- (2021) David F. McDermott et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial
- (2021) Joaquim Bellmunt et al. LANCET ONCOLOGY
- The Next Decade of Immune Checkpoint Therapy
- (2021) Padmanee Sharma et al. Cancer Discovery
- Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
- (2021) Arjun V Balar et al. LANCET ONCOLOGY
- Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
- (2021) Toni K. Choueiri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
- (2020) Meenu Sharma et al. Nature Communications
- The 100 most-cited articles in urological surgery: A bibliometric analysis
- (2020) Lugeng He et al. International Journal of Surgery
- Metastatic castration-resistant prostate cancer
- (2020) Lugeng He et al. MEDICINE
- Realigning science, society and policy in uncertain times
- (2020) Goverdhan Mehta et al. Royal Society Open Science
- Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
- (2020) Johannes Czernin et al. JOURNAL OF NUCLEAR MEDICINE
- The Immunotherapy Revolution in Kidney Cancer Treatment
- (2020) Elshad Hasanov et al. CANCER JOURNAL
- A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
- (2020) Patrick A. Ott et al. CELL
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
- (2020) Philip Cornford et al. EUROPEAN UROLOGY
- A Bibliometric Analysis of the Most Cited Articles in Neurocritical Care Research
- (2019) Miguel Bertelli Ramos et al. Neurocritical Care
- Academic Review and Perspectives on Robotic Exoskeletons
- (2019) Guanjun Bao et al. IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING
- Personalized cancer neoantigen vaccines come of age
- (2018) Yanhong Chu et al. Theranostics
- Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
- (2018) Ren-You Pan et al. Journal of Immunology Research
- Oncolytic virus therapy: A new era of cancer treatment at dawn
- (2016) Hiroshi Fukuhara et al. CANCER SCIENCE
- The US Food and Drug Administration and Cardiovascular Medicine
- (2016) Robert M. Califf CIRCULATION
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- The 100 most-cited articles in neuroimaging: A bibliometric analysis
- (2016) Hye Jeong Kim et al. NEUROIMAGE
- The 50 Most-cited Articles in Orthopaedic Surgery From Mainland China
- (2015) Zhiwei Jia et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
- (2015) Daniel Sanghoon Shin et al. CURRENT OPINION IN IMMUNOLOGY
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Human resources for research: building bridges through the Diaspora
- (2015) Karen Hofman et al. Global Health Action
- Leadership Development Programs for Physicians: A Systematic Review
- (2014) Jan C. Frich et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
- Calling for international collaborative research in nursing, genetics and genomics: A discussion paper
- (2006) Gwen Anderson et al. INTERNATIONAL JOURNAL OF NURSING STUDIES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More